Pimobendan

匹莫苯

Report date: 2022/06/22 17:20:31
NME

Base Information

Drug NamePimobendan
Drug Alias NamePimobendane匹莫苯丹匹莫苯旦PimobendanumAcardi +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1994/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC01CE
Related LinksWikipediaKEGG